Cargando…
A Study of T Cell Tolerance to the Tumor-Associated Antigen MDM2: Cytokines Can Restore Antigen Responsiveness, but Not High Avidity T Cell Function
BACKGROUND: Most tumor-associated antigens (TAA) currently used for immunotherapy of cancer are also expressed in normal tissues, which may induce tolerance and impair T cell-mediated immunity. However, there is limited information about how physiological expression in normal tissues alters the func...
Autores principales: | Bendle, Gavin M., Xue, Shao-An, Holler, Angelika, Stauss, Hans J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1831496/ https://www.ncbi.nlm.nih.gov/pubmed/17406677 http://dx.doi.org/10.1371/journal.pone.0000353 |
Ejemplares similares
-
Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells
por: Alsaieedi, Ahdab, et al.
Publicado: (2018) -
Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells
por: McGovern, Jenny, et al.
Publicado: (2022) -
CD8 T Cell Tolerance to a Tumor-Associated Self-Antigen Is Reversed by CD4 T Cells Engineered To Express the Same T Cell Receptor
por: Ghorashian, Sara, et al.
Publicado: (2015) -
Human MHC Class I-restricted high avidity CD4(+) T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo
por: Xue, Shao-An, et al.
Publicado: (2013) -
CD4(+) T Cell Subset Differentiation and Avidity Setpoint Are Dictated by the Interplay of Cytokine and Antigen Mediated Signals
por: Shiner, Erin K., et al.
Publicado: (2014)